Literature DB >> 12470304

Symptom dimensions and their association with outcome and treatment setting in long-term schizophrenia. Results of the DSP project.

Raimo K R Salokangas1, Teija Honkonen, Eija Stengård, Aanna-Maija Koivisto.   

Abstract

National representative samples of 1571 schizophrenia patients discharged from mental hospitals in Finland in 1990 and 1994 were interviewed 3 years after discharge. The symptom items assessed by the PANSS were factorized and orthogonal rotations were performed. Five factor dimensions, negative, positive, depressive, hostile and disorganization dimension, were obtained and correlated with data of patients' socio-demographic background, clinical history, condition and outcome. The negative dimension was more prominent in male and single patients, the depressive dimension in female and divorced patients. Patients with early onset and long duration of illness had high disorganization scores. Patients with disorganized subtype of schizophrenia had high scores in positive and disorganization dimensions. High scores in all, especially in negative and positive dimensions, were associated with poor psychosocial situation. Symptom dimensions varied also according to treatment setting at follow-up. Symptom dimensions of long-term schizophrenia patients in the community are closely associated with patients' socio-demographic background, clinical history and conditions, as well as with outcome and the treatment patients receive. A dimensional approach, instead of a categorical one, seems to be important in assessing symptomatology and its relation to outcome and interventions in schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12470304     DOI: 10.1080/080394802760322079

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  6 in total

1.  Symptom dimensions and outcome in schizophrenia.

Authors:  Raimo K R Salokangas
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

2.  Symptom dimensions and subgroups in childhood-onset schizophrenia.

Authors:  Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport
Journal:  Schizophr Res       Date:  2017-11-13       Impact factor: 4.939

3.  Complex interaction between symptoms, social factors, and gender in social functioning in a community-dwelling sample of schizophrenia.

Authors:  F Vila-Rodriguez; S Ochoa; J Autonell; J Usall; J M Haro
Journal:  Psychiatr Q       Date:  2011-12

4.  Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study.

Authors:  Massimiliano Buoli; Alice Caldiroli; Gabriele Panza; Alfredo Carlo Altamura
Journal:  Psychiatry Investig       Date:  2012-11-14       Impact factor: 2.505

5.  Effects of short-term inpatient treatment on sensitivity to a size contrast illusion in first-episode psychosis and multiple-episode schizophrenia.

Authors:  Steven M Silverstein; Brian P Keane; Yushi Wang; Deepthi Mikkilineni; Danielle Paterno; Thomas V Papathomas; Keith Feigenson
Journal:  Front Psychol       Date:  2013-07-24

6.  Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data.

Authors:  Elisabetta Caletti; Riccardo A Paoli; Alessio Fiorentini; Michela Cigliobianco; Elisa Zugno; Marta Serati; Giulia Orsenigo; Paolo Grillo; Stefano Zago; Alice Caldiroli; Cecilia Prunas; Francesca Giusti; Dario Consonni; A Carlo Altamura
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.